🇺🇸 FDA
Patent

US 11395822

Methods for treating Huntington's disease

granted A61KA61K31/444A61K31/5025

Quick answer

US patent 11395822 (Methods for treating Huntington's disease) held by PTC THERAPEUTICS, INC. expires Mon Jul 21 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
PTC THERAPEUTICS, INC.
Grant date
Tue Jul 26 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 21 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K31/444, A61K31/5025, A61K31/517, A61K31/519